Single-Cell and Population Transcriptomics Reveal Pan-epithelial Remodeling in Type 2-High Asthma

Nathan D Jackson1, Jamie L Everman1, Maurizio Chioccioli2

  • 1Center for Genes, Environment, and Health, National Jewish Health, Denver, CO 80206, USA.

Cell Reports
|July 9, 2020
PubMed
Summary

Interleukin-13 (IL-13) drives mucus in type 2 high (T2H) asthma by altering airway cells. This remodeling causes mucus imbalance and impaired airway function, offering new therapeutic targets.